Ubs Group Ag Brickell Biotech, Inc. Transaction History

Ubs Group Ag

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	N/A	5,838 Added 935.58%	6,462 $11,000
Q4 2022 Feb 08, 2023	BUY	$1.71 - $2.08 $593 - $721	347 Added 125.27%	624 $1,000
Q3 2022 Nov 10, 2022	BUY	$1.72 - $4.41 $476 - $1,221	277 New	277 $1,000

65K

Ticker BBI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,873,960
Market Cap $6.75M
Description
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.